Fluticasone propionate-salmeterol versus inhaled corticosteroids plus montelukast: outcomes study in pediatric patients with asthma

BACKGROUND: The purpose of this study (GSK ADA111194) was to compare asthma-related health care utilization and costs associated with fluticasone propionate (an inhaled corticosteroid [ICS]) and salmeterol (a long-acting beta-agonist) in a single inhalation device (fluticasone propionate-salmeterol)...

Descripción completa

Detalles Bibliográficos
Autores principales: Stanford, Richard H, Shah, Manan, D’Souza, Anna O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3536350/
https://www.ncbi.nlm.nih.gov/pubmed/23300347
http://dx.doi.org/10.2147/JAA.S34582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3536350/
https://www.ncbi.nlm.nih.gov/pubmed/23300347
http://dx.doi.org/10.2147/JAA.S34582

Ejemplares similares